Paperback. Zustand: Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.
Sprache: Englisch
Verlag: Wiley & Sons, Incorporated, John, 2008
ISBN 10: 0470393181 ISBN 13: 9780470393185
Anbieter: Better World Books: West, Reno, NV, USA
Zustand: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Sprache: Englisch
Verlag: Wiley & Sons, Incorporated, John, 2008
ISBN 10: 0470393181 ISBN 13: 9780470393185
Anbieter: Better World Books: West, Reno, NV, USA
Zustand: Very Good. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Sprache: Englisch
Verlag: Wiley & Sons, Incorporated, John, 2008
ISBN 10: 0470393181 ISBN 13: 9780470393185
Anbieter: Better World Books, Mishawaka, IN, USA
Zustand: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Paperback. Zustand: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less.
Paperback. Zustand: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Paperback. Zustand: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less.
Sprache: Englisch
Verlag: Wiley & Sons, Incorporated, John, 2008
ISBN 10: 0470393181 ISBN 13: 9780470393185
Anbieter: Better World Books Ltd, Dunfermline, Vereinigtes Königreich
EUR 6,61
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Zustand: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.
Anbieter: WorldofBooks, Goring-By-Sea, WS, Vereinigtes Königreich
EUR 8,13
Anzahl: 3 verfügbar
In den WarenkorbPaperback. Zustand: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged.
EUR 27,41
Anzahl: 15 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
EUR 31,46
Anzahl: 3 verfügbar
In den WarenkorbZustand: New. pp. xiv + 136 Illus.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 35,43
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 1st edition. 136 pages. 9.06x6.06x0.47 inches. In Stock.
Zustand: New. This book answers the questions about the process and costs of pharmaceutical R & D in a compelling narrative focused on the discovery and development of important new medicines. Num Pages: 152 pages, Illustrations. BIC Classification: KNDP. Category: (G) General (US: Trade). Dimension: 231 x 175 x 11. Weight in Grams: 280. . 2008. 1st Edition. Paperback. . . . . Books ship from the US and Ireland.
EUR 29,97
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. John L. LaMattina, PhD, retired as president of Pfizer Global Research and Development in 2007 where he managed more than 13,000 scientists and support professionals in the United States, Europe, and Asia. Dr. LaMattina has received numerous awards includin.
Taschenbuch. Zustand: Neu. Neuware - An insider's perspective on the pharmaceutical industryIt's easy to hate Big Pharma. After all, they charge a lot of money for life-saving drugs. You could argue that Big Pharma's incentive to generate income is antithetical to the needs of society. But, if you set costs aside, no reasonable person could argue against the industry's accomplishments. The pharmaceutical industry has cured many infectious diseases and some cancers, delayed the onset of heart disease, enabled AIDS patients to live long and productive lives, controlled the progression of arthritis, and reduced pain.Any thoughtful discussion on the pharmaceutical industry must be guided by the facts. Author John LaMattina, a thirty-year veteran and former president of Pfizer Global Research and Development, takes you through the realities and the myths surrounding the pharmaceutical industry, offering concrete illustrative examples. Rather than innuendo, he offers facts, answering your questions about the process and costs of pharmaceutical R&D in a compelling narrative focused on the discovery and development of new medicines.Divided into four parts, this book dispels common misconceptions, helping you arrive at your own informed conclusions:\* Part One, A Matter of the Heart\* Part Two, The Role of Pharmaceutical R&D in Healthcare\* Part Three, The Profit Motive\* Part Four, The FutureWith its emphasis on fact, John LaMattina's book is indispensable for anyone interested in understanding, advocating, or setting pharmaceutical policy, including general consumers, pharmaceutical executives, regulators, pharmaceutical researchers, and students.'This is an important and timely book.'-Dr. Richard A. Lerner, President of the Scripps Research Institute'Drug Truths is an authoritative, clear, and accessible exposition of the realities of drug discovery and development.'-Professor E.J. Corey, Nobel Laureate, Harvard University.
Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Answering questions about the process and costs of pharmaceutical R & D, this compelling narrative focuses on the discovery and development of important new medicines. It gives an insider's account of the drug discovery process, how misperceptions about the industry have real costs, the high stakes-both economic and scientific-of developing drugs, the triumphs when new compounds reach the market and save lives, and the despair when new compounds fail. This is a story that John LaMattina, former president of Pfizer Global Research and Development, is uniquely qualified to tell.